19.61
전일 마감가:
$18.80
열려 있는:
$18.95
하루 거래량:
170.83K
Relative Volume:
0.87
시가총액:
$350.30M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-140.07
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
+1.24%
1개월 성능:
+3.49%
6개월 성능:
-10.18%
1년 성능:
+102.80%
Rigel Pharmaceuticals Stock (RIGL) Company Profile
명칭
Rigel Pharmaceuticals
전화
650-624-1100
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RIGL
Rigel Pharmaceuticals
|
19.60 | 345.83M | 116.88M | -25.09M | -20.74M | -0.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.63 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.71 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.92 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
565.44 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.14 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-04-03 | 재개 | Piper Sandler | Neutral |
2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-06-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2022-06-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2022-03-23 | 개시 | B. Riley Securities | Neutral |
2020-11-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2019-11-15 | 재개 | Cantor Fitzgerald | Overweight |
2019-09-26 | 재개 | JP Morgan | Overweight |
2019-03-01 | 재확인 | Cantor Fitzgerald | Overweight |
2018-08-27 | 개시 | Citigroup | Buy |
2018-05-02 | 재확인 | Cantor Fitzgerald | Overweight |
2017-12-21 | 재개 | Piper Jaffray | Overweight |
2017-12-15 | 개시 | Cantor Fitzgerald | Overweight |
2017-11-06 | 재개 | H.C. Wainwright | Buy |
2017-03-09 | 재확인 | H.C. Wainwright | Buy |
2016-08-31 | 재확인 | H.C. Wainwright | Buy |
2016-08-30 | 재확인 | Piper Jaffray | Overweight |
2016-07-13 | 개시 | H.C. Wainwright | Buy |
2016-06-13 | 개시 | Piper Jaffray | Overweight |
2016-04-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
2013-04-08 | 재확인 | Stifel | Buy |
2012-11-29 | 개시 | UBS | Neutral |
2012-11-06 | 재확인 | Oppenheimer | Outperform |
2012-03-26 | 개시 | Canaccord Genuity | Hold |
2010-12-10 | 다운그레이드 | MP Advisors | Outperform → Market Perform |
모두보기
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
What analysts say about Rigel Pharmaceuticals Inc. stockAccelerated investment success - PrintWeekIndia
(RIGL) Proactive Strategies - news.stocktradersdaily.com
Is Rigel Pharmaceuticals Inc. a good long term investmentUnstoppable profit momentum - Autocar Professional
Rigel Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com
What drives Rigel Pharmaceuticals Inc. stock priceTriple-digit returns - jammulinksnews.com
What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com
Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey
(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | RIGL Stock News - GuruFocus
Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛
Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com
High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com
Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World
Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria
Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com
Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq
Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider
Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow
Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise
Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus
Rigel to Present at the Jefferies Global Healthcare Conference – Company Announcement - Financial Times
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire
Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World
(RIGL) Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
Rigel Pharmaceuticals (RIGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):